ISR most commonly stands for injection site reaction, the localized response your body has after receiving a shot. It can also stand for in-stent restenosis, a cardiology term for the re-narrowing of an artery after a stent has been placed. Both are widely referenced in medical settings, so this article covers each one in detail.
Injection Site Reactions: The Basics
An injection site reaction is your immune system’s localized response to a needle puncture and whatever substance was injected. The most common symptoms are soreness, redness, swelling, warmth, and tenderness right around the spot where the needle went in. These reactions happen with vaccines, insulin injections, biologic medications, and many other types of shots.
Nearly every vaccine on the CDC’s schedule lists some form of injection site reaction as a possible side effect. A sore arm after a flu shot, redness after an HPV vaccine, or swelling after a shingles shot are all textbook examples. The shingles vaccine is particularly known for causing moderate arm pain in most people who receive it.
Why Your Body Reacts to Injections
When a needle breaks the skin and delivers a substance into tissue, your immune system treats the area as a minor threat. The injected substance triggers the release of signaling molecules called cytokines, which cause the redness, warmth, and swelling you see and feel. This is a normal inflammatory response, not a sign that something went wrong.
Some reactions are driven by a more specific immune pathway. Your body may produce antibodies against the injected substance, leading to either an immediate response (a raised, red bump within minutes) or a delayed one that shows up hours to days later. Delayed reactions are more common with biologic medications used to treat conditions like rheumatoid arthritis or high cholesterol. These delayed responses can sometimes require higher doses of the medication over time as the body learns to neutralize it faster.
How Long an ISR Lasts
Most injection site reactions appear within a few hours of the shot. Tenderness tends to be worst in the first several hours and then gradually fades, even as visible redness or swelling increases. The reaction typically peaks around 24 to 48 hours after the injection. For vaccines and most medications, everything resolves within three to five days.
With biologic drugs, reactions can be more persistent. Some patients experience ISRs that take a full week to clear, and in rare cases, symptoms linger for longer. Reactions to biologics are most common during the first one to two months of starting treatment, then often decrease as the body adjusts.
Managing an Injection Site Reaction at Home
A cold compress applied to the injection site is the simplest and most effective first step. It reduces swelling and numbs the area. Over-the-counter pain relievers can help with soreness, and anti-itch medication is useful if the site becomes itchy. Beyond that, most ISRs don’t need any intervention at all.
If you give yourself regular injections (for insulin, for example), proper technique makes a real difference in how often reactions occur. Using a shorter needle, ideally 4 mm for pen needles, reduces the chance of injecting too deep into muscle tissue. Rotating your injection sites systematically prevents a condition called lipohypertrophy, where repeated injections in the same spot cause the tissue to harden and swell. Needles longer than 8 mm should generally be avoided, and reusing needles significantly increases the risk of local reactions.
Normal Reaction vs. Something More Serious
The key distinction is between a typical ISR and an actual skin infection like cellulitis. A normal injection site reaction causes redness and swelling that spread gradually, with tenderness that decreases over the first day even as the visible reaction grows. Fever is uncommon, and you generally feel fine otherwise.
Cellulitis, by contrast, produces redness that can expand rapidly (within 12 to 24 hours for certain bacteria), along with increasing pain, significant warmth, and usually a fever with a general feeling of being unwell. If your injection site is getting more painful rather than less painful as time goes on, if the redness is spreading quickly and feels hot to the touch, or if you develop a fever and feel sick, those are signs of a possible infection rather than a routine reaction.
ISR in Cardiology: In-Stent Restenosis
In cardiology, ISR stands for in-stent restenosis. This is when an artery that was previously opened with a stent gradually narrows again. A stent is a small mesh tube placed inside a blocked coronary artery to hold it open and restore blood flow. Restenosis means that new tissue grows inside the stent, partially or fully blocking the artery again.
The problem emerged in the mid-1990s when bare-metal stents first became widely used. With those early stents, about 14.7% of patients developed restenosis. Modern drug-eluting stents, which slowly release medication to prevent tissue overgrowth, have dropped that rate dramatically to around 2.5%. Still, even with the latest stent technology, restenosis occurs at a rate of roughly 1 to 2% per year, and that risk persists for as long as the stent is in place.
What Causes In-Stent Restenosis
When a stent is placed, the procedure unavoidably damages the inner lining of the artery. This triggers inflammation and a healing response. Smooth muscle cells in the artery wall begin to multiply and migrate inward, forming a layer of new tissue inside the stent. This process, called neointimal hyperplasia, is essentially the artery’s attempt to heal itself, but it can overshoot and create a new blockage.
Drug-eluting stents work by releasing compounds that slow down cell growth, keeping that tissue buildup in check. With bare-metal stents, restenosis tends to happen relatively soon after placement. Drug-eluting stents push the risk further out in time but don’t eliminate it entirely. In some long-term cases, a process resembling new plaque buildup (neoatherosclerosis) can also develop within the stent.
How In-Stent Restenosis Is Detected
Doctors define ISR as more than 50% narrowing within or immediately next to a previously stented section of artery, as seen on an angiogram. But not every case of narrowing causes symptoms. Clinical restenosis, the kind that matters to patients, is when the blockage becomes severe enough to reduce blood flow and cause chest pain, shortness of breath, or other signs of restricted circulation to the heart.
When doctors suspect restenosis, they use imaging techniques to confirm it. Standard angiography (where dye is injected and X-rays are taken) provides a broad view, while more advanced tools like optical coherence tomography offer much finer detail. These imaging methods can reveal whether the stent is sitting properly against the artery wall, whether tissue is protruding through the mesh, and how much new blockage has formed. For borderline cases, functional tests can determine whether the narrowing is actually restricting blood flow enough to require treatment, since moderate narrowing doesn’t always need another procedure.